Athersys (ATHX) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Athersys Reports Second Quarter 2016 Results
August 9, 2016 4:03 PM EDTCLEVELAND, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) today announced its financial results for the three months ended June 30, 2016.
Highlights of the second quarter of 2016 include:
Successful discussions with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) on ischemic stroke study design and requirements, led by HEALIOS K.K. (Healios) with Athersys support, laying the groundwork for study initiation later this year;Productive discussions with U.S. Food and Drug Administration (FDA) about the design of our planned international Phase 3 study of MultiStem® treatment for... More
